ZEB1 and hepatocellular carcinoma: According to the authors, antagonizing H19 diminished the expression of zinc finger E-box binding homeobox 1 (ZEB1) and P-gp, and upregulated the expression of E-cadherin (EC); thus, the chemotherapy resistance of HCC cells was reversed by blocking the EMT process (Li et al. 2019).